AR052990A1 - Farmaco para administracion higienica al oido - Google Patents
Farmaco para administracion higienica al oidoInfo
- Publication number
- AR052990A1 AR052990A1 ARP050105158A ARP050105158A AR052990A1 AR 052990 A1 AR052990 A1 AR 052990A1 AR P050105158 A ARP050105158 A AR P050105158A AR P050105158 A ARP050105158 A AR P050105158A AR 052990 A1 AR052990 A1 AR 052990A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaco
- ear
- hygienic
- administration
- hygienic administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
Abstract
Sistema que contiene un fármaco para administracion higiénica de un medicamento otico, especialmente en animales, que incluso a bajos volumenes ha de dosificarse reproduciblemente y que no se expulse incluso al agitar la cabeza.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004059220 | 2004-12-09 | ||
DE102005055385A DE102005055385A1 (de) | 2004-12-09 | 2005-11-17 | Arzneimittel zur hygienischen Applikation im Ohr |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052990A1 true AR052990A1 (es) | 2007-04-18 |
Family
ID=35735089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050105158A AR052990A1 (es) | 2004-12-09 | 2005-12-09 | Farmaco para administracion higienica al oido |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090011045A1 (es) |
EP (1) | EP1830803A2 (es) |
JP (1) | JP2008522998A (es) |
KR (1) | KR20070086799A (es) |
AR (1) | AR052990A1 (es) |
AU (1) | AU2005313602A1 (es) |
BR (1) | BRPI0518855A2 (es) |
CA (1) | CA2594103A1 (es) |
CR (1) | CR9142A (es) |
DE (1) | DE102005055385A1 (es) |
GT (1) | GT200500361A (es) |
IL (1) | IL183744A0 (es) |
MX (1) | MX2007006689A (es) |
NO (1) | NO20073148L (es) |
NZ (1) | NZ555640A (es) |
PE (1) | PE20061145A1 (es) |
RU (1) | RU2431486C2 (es) |
TW (1) | TW200637611A (es) |
WO (1) | WO2006061156A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
DE102007055341A1 (de) * | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
GR20090100230A (el) | 2009-04-14 | 2010-11-18 | Casso Pharmaceuticals Ε.Π.Ε, | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
CA2862406A1 (en) * | 2012-01-10 | 2013-07-18 | Entrx LLC | Otic formulations, methods and devices |
US9849126B2 (en) | 2013-01-03 | 2017-12-26 | Entrx LLC | Sterile otic formulations |
MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
KR20180121493A (ko) | 2015-12-29 | 2018-11-07 | 갈데르마 소시에떼아노님 | 바이오폴리머의 탈아세틸화 방법 |
CN109689027A (zh) * | 2016-06-29 | 2019-04-26 | 奥德纳米有限公司 | 甘油三酯耳用制剂及其用途 |
UA124124C2 (uk) * | 2017-02-13 | 2021-07-21 | Баєр Енімал Хелс Гмбх | Рідка композиція, що містить прадофлоксацин |
JP7410050B2 (ja) | 2018-04-25 | 2024-01-09 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | キノロンカルボン酸エステルの加水分解プロセス |
PE20211892A1 (es) | 2019-02-19 | 2021-09-22 | Salvat Lab Sa | Composicion liquida de clotrimazol envasada de dosis unica |
US11235087B2 (en) * | 2019-10-28 | 2022-02-01 | Galderma Holding SA | Ready-to-use esthetic compositions |
RU2758056C2 (ru) * | 2019-11-21 | 2021-10-26 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Препарат для лечения отитов бактериальной и грибковой этиологии у собак |
WO2021111303A1 (en) | 2019-12-02 | 2021-06-10 | Galderma Holding SA | High molecular weight esthetic compositions |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US4472405A (en) * | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
US4730000A (en) * | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
JPS6032714A (ja) * | 1983-08-01 | 1985-02-19 | Teijin Ltd | 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物 |
DE3333719A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
JPS61167614A (ja) * | 1985-01-22 | 1986-07-29 | Mitsubishi Yuka Yakuhin Kk | ステロイド含有軟膏剤 |
AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
IN166416B (es) * | 1985-09-18 | 1990-05-05 | Pfizer | |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
DE3713672A1 (de) * | 1987-04-24 | 1988-11-17 | Bayer Ag | Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren |
US5444096A (en) * | 1989-06-02 | 1995-08-22 | Helene Curtis, Inc. | Stable anhydrous topically-active composition and suspending agent therefor |
US5665384A (en) * | 1990-04-06 | 1997-09-09 | Rhone-Poulenc Rorer S.A. | Oily capsules of ketoprofen |
DE19500784A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Enrofloxacin-Injektions- oder Infusionslösungen |
IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
US5843930A (en) * | 1995-06-06 | 1998-12-01 | Bayer Corporation | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
CA2176298C (en) * | 1995-06-27 | 2009-01-27 | Dennis D. Copeland | A single high dose fluoroquinolone treatment |
US5753269A (en) * | 1995-12-27 | 1998-05-19 | Bayer Corporation | Otic microbial combinations |
DE59708771D1 (de) * | 1996-02-23 | 2003-01-02 | Bayer Ag | Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate |
US5972920A (en) * | 1998-02-12 | 1999-10-26 | Dermalogix Partners, Inc. | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
FR2781373B1 (fr) * | 1998-07-07 | 2001-09-21 | Pf Medicament | Formulations thixotropes pour le remplissage de gelules |
AR020661A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
DE19854355A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
ES2286998T3 (es) * | 1999-02-26 | 2007-12-16 | Sanofi-Aventis | Formulacion estable que contiene fumagillina. |
EP1181013B1 (en) * | 1999-04-14 | 2006-10-11 | Dana-Farber Cancer Institute, Inc. | Method and composition for the treatment of cancer |
HUP0303696A3 (en) * | 2000-09-25 | 2005-05-30 | Bayer Healthcare Llc Tarrytown | Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
ES2171147B1 (es) * | 2001-02-06 | 2003-12-16 | Esteve Labor Dr | Preparacion para usos veterinarios. |
BR0212898A (pt) * | 2001-09-21 | 2004-10-13 | Alcon Inc | Método de tratamento de infecções do ouvido médio |
US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20050159369A1 (en) * | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
JP2007511521A (ja) * | 2003-11-13 | 2007-05-10 | コンビナトアールエックス インコーポレーティッド | 炎症性障害を治療する方法および試薬 |
US7764972B2 (en) * | 2004-02-17 | 2010-07-27 | Vocera Communications, Inc. | Heterogeneous device chat room system and method |
PL1776109T3 (pl) * | 2004-08-13 | 2009-06-30 | Schering Plough Ltd | Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid |
-
2005
- 2005-11-17 DE DE102005055385A patent/DE102005055385A1/de not_active Withdrawn
- 2005-12-03 BR BRPI0518855-5A patent/BRPI0518855A2/pt not_active IP Right Cessation
- 2005-12-03 RU RU2007125570/15A patent/RU2431486C2/ru not_active IP Right Cessation
- 2005-12-03 WO PCT/EP2005/012978 patent/WO2006061156A2/de active Application Filing
- 2005-12-03 NZ NZ555640A patent/NZ555640A/en not_active IP Right Cessation
- 2005-12-03 CA CA002594103A patent/CA2594103A1/en not_active Abandoned
- 2005-12-03 EP EP05816509A patent/EP1830803A2/de not_active Withdrawn
- 2005-12-03 MX MX2007006689A patent/MX2007006689A/es not_active Application Discontinuation
- 2005-12-03 KR KR1020077014903A patent/KR20070086799A/ko not_active Application Discontinuation
- 2005-12-03 AU AU2005313602A patent/AU2005313602A1/en not_active Abandoned
- 2005-12-03 US US11/721,204 patent/US20090011045A1/en not_active Abandoned
- 2005-12-03 JP JP2007544787A patent/JP2008522998A/ja active Pending
- 2005-12-07 PE PE2005001419A patent/PE20061145A1/es not_active Application Discontinuation
- 2005-12-08 TW TW094143288A patent/TW200637611A/zh unknown
- 2005-12-08 GT GT200500361A patent/GT200500361A/es unknown
- 2005-12-09 AR ARP050105158A patent/AR052990A1/es not_active Application Discontinuation
-
2007
- 2007-05-23 CR CR9142A patent/CR9142A/es unknown
- 2007-06-07 IL IL183744A patent/IL183744A0/en unknown
- 2007-06-20 NO NO20073148A patent/NO20073148L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2594103A1 (en) | 2006-06-15 |
RU2007125570A (ru) | 2009-01-20 |
NO20073148L (no) | 2007-08-22 |
CR9142A (es) | 2007-12-04 |
TW200637611A (en) | 2006-11-01 |
WO2006061156A3 (de) | 2006-08-24 |
MX2007006689A (es) | 2007-08-14 |
AU2005313602A1 (en) | 2006-06-15 |
GT200500361A (es) | 2006-11-07 |
JP2008522998A (ja) | 2008-07-03 |
WO2006061156A2 (de) | 2006-06-15 |
PE20061145A1 (es) | 2006-12-29 |
EP1830803A2 (de) | 2007-09-12 |
BRPI0518855A2 (pt) | 2008-12-09 |
RU2431486C2 (ru) | 2011-10-20 |
KR20070086799A (ko) | 2007-08-27 |
US20090011045A1 (en) | 2009-01-08 |
NZ555640A (en) | 2009-12-24 |
DE102005055385A1 (de) | 2006-06-14 |
IL183744A0 (en) | 2008-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR052990A1 (es) | Farmaco para administracion higienica al oido | |
RS52367B (en) | GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES | |
EA200700340A1 (ru) | Мультичастицы | |
EA200800360A1 (ru) | Формуляции с высоким содержанием лекарства и дозированные формы | |
BRPI0816887A2 (pt) | Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga | |
WO2006124681A3 (en) | Oral drug delivery system and methods of use thereof | |
EA200601759A1 (ru) | Композиции рамиприла | |
PT1500654E (pt) | Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos | |
CY1112158T1 (el) | Yπoδoxeaς γia xophγoymena yγpa φapmaka | |
MX2007000420A (es) | Suplemento de electrolito y metodo de uso. | |
CL2011000187A1 (es) | Preparacion farmaceutica que comprende (5-metil-2-oxo-1,3-dioxol-4il)metil 2-etoxi-1-{[2,{5-oxo-4,5-dihidro-1,2,4-oxadiazol-3-il)bifenil4il]metil}-1h-benzimidazol-7-carboxilato, un agente de control de ph entre 2 y 5 y un diuretico; metodo para estabilizar; metodo para mejorar disolucion, util en enfermedades inducidas por angiotensina ii. | |
ITMI20040954A1 (it) | Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica | |
ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol | |
UY29252A1 (es) | Farmaco para administracion higienica al oido | |
Sacks et al. | Reconstruction, destruction and IVF: dilemmas in the art of tubal surgery. | |
UA92731C2 (ru) | Лекарственное средство для гигиеничной обработки уха | |
MX2010008285A (es) | Forma galenica para la administracion de triptanos por via trans-mucosa bucal. | |
EA200800150A1 (ru) | Состав с пролонгированным высвобождением действующих начал лекарственного средства | |
SV2006002224A (es) | Composicion farmaceutica ref. bhco41368-sv | |
PA8560601A1 (es) | Combinacion farmaceutica | |
DE60312642D1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
AR049220A1 (es) | Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos | |
DE602007003854D1 (de) | Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen | |
于元元 | A New Quest for the Main Thread into the Waste Land | |
钟祥 et al. | Fun Time |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |